Gut-microbiota polyphenol metabolites and bone health: an abstract review
The abstract reviews evidence that polyphenol metabolites made by gut bacteria may support bone health; strongest evidence is for S-(−)-equol, with promising results for urolithin A. [1]
Automatic summary · not editorially reviewed
The key findings
The source at a glance
- Study type / format
- Abstract of a review summarizing evidence by study type
- Population / context
- Humans, with postmenopausal women highlighted as at particular osteoporosis risk
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- September 28, 2026
Bone remodeling, osteoporosis risk and polyphenol-rich diets
Bone strength depends on remodeling that balances bone resorption and formation; an imbalance raises turnover and causes bone loss. Osteoporosis means excessive loss of bone mineral density and deteriorating bone microarchitecture with more fragility fractures, and it is common in older people, especially postmenopausal women. The abstract notes that clinical studies report a positive impact of polyphenol-rich nutrition on bone health.
Supporting source [1]
Microbial metabolites: obligatory versus facultative sources
Beyond phenolic compounds present in foods, gut microbiota generate additional potentially bioactive molecules from polyphenol precursors, and these may contribute significantly to dietary polyphenol effects. Some, like urolithins or equol, are made exclusively by gut bacteria and occur in no food source (obligatory microbial metabolites). Others, like caffeic or vanillic acid, may come from microbial transformation of precursors or occur naturally in foods (facultative microbial metabolites).
Supporting source [1]
Evidence by study type: equol strongest, urolithin A promising
Evidence for bioactivity of these metabolites on bone-relevant cellular pathways and metabolic bone markers is summarized by study type. The abstract states it seems likely that individual polyphenol-derived microbial metabolites contribute to bone-protective effects in humans. Strongest evidence is available for S-(−)-equol, and consistent promising results exist for urolithin A. Structurally unrelated metabolites often target the same signaling pathways. Supplementation with polyphenols appears reasonable as primary prevention for people at risk of osteoporosis or in the pre-therapeutic stage.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The abstract does not report study designs, sample sizes, follow-up or effect sizes, and it describes potential effects rather than proven causal benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Scherg C, Högger P. · europepmc.org · September 28, 2026